Wolverine Asset Management LLC Omeros Corp Transaction History

Wolverine Asset Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$3.09 - $7.46 $74,160 - $179,040	24,000 Added 39.73%	84,412 $265,000
Q2 2022 Aug 03, 2022	BUY	$1.92 - $6.28 $37,056 - $121,204	19,300 Added 46.94%	60,412 $166,000
Q4 2021 Feb 09, 2022	BUY	$5.67 - $8.54 $204,664 - $308,259	36,096 Added 719.62%	41,112 $264,000
Q1 2021 May 13, 2021	BUY	$14.52 - $23.53 $72,832 - $118,026	5,016 New	5,016 $89,000
Q1 2020 May 13, 2020	SELL	$9.03 - $19.72 $195,382 - $426,681	-21,637 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$13.01 - $17.15 $154,571 - $203,759	11,881 Added 121.78%	21,637 $304,000
Q3 2019 Nov 14, 2019	BUY	$14.55 - $20.56 $57,559 - $81,335	3,956 Added 68.21%	9,756 $159,000
Q2 2019 Aug 14, 2019	SELL	$15.0 - $19.62 $2.01 Million - $2.63 Million	-133,877 Reduced 95.85%	5,800 $91,000
Q4 2018 Feb 14, 2019	BUY	$10.72 - $16.73 $1.5 Million - $2.34 Million	139,677 New	139,677 $1.56 Million

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $684M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.